文献速递头颈部肿瘤放疗放疗物理与技术

头颈部SABR中基于靶区部位分析定位与分次内精度估算PTV margin

Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-09-30

本研究前瞻性收集79例复发或既往照射头颈癌患者共405次SABR治疗分次的数据,比较颅底、颈部/腮腺和黏膜三个亚部位的摆位与定位精度。结果显示颅底部位的分次间和分次内误差显著低于其他部位,最终PTV margin分别为颅底1.5 mm、颈部/腮腺2.0 mm、黏膜1.8 mm,提示头颈SABR的PTV margin应按靶区部位优化。

要点

  • 颅底SABR的PTV margin为1.5 mm,颈部/腮腺为2.0 mm,黏膜为1.8 mm
  • 使用ExacTrac时颈部/黏膜靶区可能需要加用CBCT以校正摆位误差和器官运动

核心结论

  • 头颈SABR的PTV margin应按靶区部位优化,颅底1.5至2 mm可能足够,颈部与黏膜靶区可能需要2至2.5 mm。
  • 使用ExacTrac时颅底部位全程不确定性显著更少,颈部/黏膜靶区可能需要加用CBCT以校正摆位误差和器官运动。

研究设计与样本

  • 前瞻性研究,纳入79例接受SABR治疗的复发或既往照射头颈癌患者,共405次治疗分次。
  • 通过ExacTrac X线对比治疗计划确定分次间误差,复位后重复X线测量残余误差,再将CBCT与ExacTrac对比定位一致性,最后在每个弧前用X线测量分次内误差。
  • 结果按治疗部位分层为颅底、颈部/腮腺和黏膜。

主要发现

  • 多数患者(66.7%)接受45 Gy分5次治疗(范围21-47.5 Gy分3-5次)。
  • 初始分次间平均误差±标准差为前后-0.2±1.4 mm、头脚0.2±1.8 mm、左右-0.1±1.7 mm。
  • 所有分次间误差校正至1.3 mm和1.8°以内;CBCT与ExacTrac一致性在3.6 mm和3.4°以内。

关键数值与推荐

  • 最终PTV margin:颅底1.5 mm,颈部/腮腺2.0 mm,黏膜1.8 mm。
  • 结论推荐颅底PTV margin 1.5至2 mm可能足够,颈部与黏膜靶区可能需要2至2.5 mm。

临床怎么用

  • 头颈SABR计划设计时应按靶区部位分别设定PTV margin,颅底可采用较小margin,颈部/腮腺和黏膜靶区需较大margin。
  • 使用ExacTrac定位时,颈部/黏膜靶区建议加用CBCT以校正摆位误差和器官运动带来的不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recurrent or previously irradiated head and neck cancers (HNC) are therapeutically challenging and may benefit from high-dose, highly accurate radiation techniques, such as stereotactic ablative radiation therapy (SABR). Here, we compare set-up and positioning accuracy across HNC subsites to further optimize the treatment process and planning target volume (PTV) margin recommendations for head and neck SABR. METHODS AND MATERIALS: We prospectively collected data on 405 treatment fractions across 79 patients treated with SABR for recurrent/previously irradiated HNC. First, interfractional error was determined by comparing ExacTrac x-ray to the treatment plan. Patients were then shifted and residual error was measured with repeat x-ray. Next, cone beam computed tomography (CBCT) was compared with ExacTrac for positioning agreement, and final shifts were applied. Lastly, intrafractional error was measured with x-ray before each arc. Results were stratified by treatment site into skull base, neck/parotid, and mucosal. RESULTS: Most patients (66.7%) were treated to 45 Gy in 5 fractions (range, 21-47.5 Gy in 3-5 fractions). The initial mean ± standard deviation interfractional errors were -0.2 ± 1.4 mm (anteroposterior), 0.2 ± 1.8 mm (craniocaudal), and -0.1 ± 1.7 mm (left-right). Interfractional 3-dimensional vector error was 2.48 ± 1.44, with skull base significantly lower than other sites (2.22 vs 2.77; P = .0016). All interfractional errors were corrected to within 1.3 mm and 1.8°. CBCT agreed with ExacTrac to within 3.6 mm and 3.4°. CBCT disagreements and intrafractional errors of >1 mm or >1° occurred at significantly lower rates in skull base sites (CBCT: 16.4% vs 50.0% neck, 52.0% mucosal, P < .0001; intrafractional: 22.0% vs 48.7% all others, P < .0001). Final PTVs were 1.5 mm (skull base), 2.0 mm (neck/parotid), and 1.8 mm (mucosal). CONCLUSIONS: Head and neck SABR PTV margins should be optimized by target site. PTV margins of 1.5 to 2 mm may be sufficient in the skull base, whereas 2 to 2.5 mm may be necessary for neck and mucosal targets. When using ExacTrac, skull base sites show significantly fewer uncertainties throughout the treatment process, but neck/mucosal targets may require the addition of CBCT to account for positioning errors and internal organ motion.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Mesko S, Wang H, Tung S, et al. Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31580928. doi:10.1016/j.ijrobp.2019.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。